CLINUVEL PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.57 AUD | -2.80% |
|
+1.32% | -8.94% |
| Mar. 14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
| Mar. 14 | Morgans Financial Upgrades Clinuvel Pharmaceuticals to Add From Hold; Price Target is AU$16 | MT |
Evolution of the average Target Price on Clinuvel Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
39fc322623.yVD4ebrpZhR6LxN0qdUBfr1sz2IeXhu4MQjMEUCeUrs.ljKQC-CDD0wKHV4e55pXKts0uA1kMi7WWGaCRRr9KviufaA2yJwtcg9VYA~3711407c5dd41db3d14fcc450bb54c35
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
14.57
AUD
Average target price
25.6
AUD
Spread / Average Target
+75.72%
High Price Target
46.3
AUD
Spread / Highest target
+217.78%
Low Price Target
16
AUD
Spread / Lowest Target
+9.81%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Clinuvel Pharmaceuticals Limited
| Morgans Financial |
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- CUV Stock
- Consensus Clinuvel Pharmaceuticals Limited
